05/2009 - Državni zavod za intelektualno vlasništvo
05/2009 - Državni zavod za intelektualno vlasništvo
05/2009 - Državni zavod za intelektualno vlasništvo
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
1986 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, <strong>2009</strong>, 5, 1863 – 2065MKP Broj objave europske Naziv izumaprijave patenta(51) (97) (54)A61K 31/519 (2006.01) EP 2046332 * CONCENTRATED METHOTREXATE SOLUTIONSA61K 31/519 (2006.01) EP 2046333 * THIOZOLIDINEDIONE DERIVATIVES AS P13 KINASE INHIBITORSA61K 31/519 (2006.01) EP 2046799 * PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND PHARMACEUTICALCOMPOSITIONS CONTAINING THEMA61K 31/519 (2006.01) EP 2049546 * DIHYDROFURO PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORSA61K 31/519 (2006.01) EP 2<strong>05</strong>1982 * 6,6-BICYCLIC RING SUBSTITUTED SULFUR CONTAINING HETEROBICYCLIC PROTEINKINASE INHIBITORSA61K 31/519 (2006.01) EP 2<strong>05</strong>4418 * DIHYDROTHIENO PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORSA61K 31/519 (2006.01) EP 2<strong>05</strong>4421 * PYRAZOLOPYRIMIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE ASMEDICINEA61K 31/52 (2006.01) EP 2018388 * BISADENOSINE COMPOUNDS AS ADENOSINE A2A RECEPTOR AGONISTSA61K 31/52 (2006.01) EP 2<strong>05</strong>4<strong>05</strong>9 * TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITYA61K 31/522 (2006.01) EP 2046793 * FUSED PYRIMIDO COMPOUNDSA61K 31/53 (2006.01) EP 2046763 * AURORA KINASE INHIBITORS FROM AN ENCODED SMALL MOLECULE LIBRARYA61K 31/535 (2006.01) EP 2049118 * MORPHOLINYL AND PYRROLIDINYL ANALOGSA61K 31/535 (2006.01) EP 2049530 * CRYSTALLINE NEMORUBICIN HYDROCHLORIDEA61K 31/5377 (2006.01) EP 2<strong>05</strong>4<strong>05</strong>9 * TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITYA61K 31/538 (2006.01) EP 2<strong>05</strong>1714 * DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASESA61K 31/538 (2006.01) EP 2<strong>05</strong>4034 * AEROSOL FORMULATION COMPRISING BETA-AGONISTS AND STEROIDSA61K 31/538 (2006.01) EP 2<strong>05</strong>4084 * AEROSOL FORMULATION FOR THE INHALATION OF BETA AGONISTSA61K 31/54 (2006.01) EP 2049120 * UROTENSIN II RECEPTOR ANTAGONISTSA61K 31/55 (2006.01) EP 2046338 * CORTICOSTEROID FOR THE TREATMENT OF INFLAMMATORY OR ALLERGICCONDITIONSPHARMACEUTICAL FORMULATIONS COMPRISING AZELASTINE AND AA61K 31/55 (2006.01) EP 2049472 * CYCLOPROPYL AMINE DERIVATIVES AS HISTAMIN H3 RECEPTOR MODULATORSA61K 31/55 (2006.01) EP 2<strong>05</strong>4417 * FUSED THIOPHENE DERIVATIVES AS MEK INHIBITORSA61K 31/5517 (2006.01) EP 2047852 * USE OF FLUMAZENIL IN THE PRODUCTION OF A MEDICAMENT FOR THE TREATMENTOF DEPRESSIVE DISORDERSA61K 31/5575 (2006.01) EP 2<strong>05</strong>53<strong>05</strong> * EXTERNAL PREPARATION COMPRISING PROSTAGLANDIN DERIVATIVEA61K 31/56 (2006.01) EP 2046338 * CORTICOSTEROID FOR THE TREATMENT OF INFLAMMATORY OR ALLERGICCONDITIONSPHARMACEUTICAL FORMULATIONS COMPRISING AZELASTINE AND AA61K 31/565 (2006.01) EP 2<strong>05</strong>4034 * AEROSOL FORMULATION COMPRISING BETA-AGONISTS AND STEROIDSA61K 31/573 (2006.01) EP 2049123 * DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID DISEASEA61K 31/60 (2006.01) EP 2<strong>05</strong>4045 * USE OF 2,5-DIHYDROXYBENZENE DERIVATIVES FOR THE TREATMENT OF ARTHRITISAND PAINA61K 31/60 (2006.01) EP 2<strong>05</strong>4<strong>05</strong>1 * USE OF 2,5-DIHYDROXYBENZENE DERIVATIVES FOR TREATING ACTINIC KERATOSISA61K 31/618 (2006.01) EP 2047845 * ADHESIVE PREPARATIONA61K 31/618 (2006.01) EP 2<strong>05</strong>4045 * USE OF 2,5-DIHYDROXYBENZENE DERIVATIVES FOR THE TREATMENT OF ARTHRITISAND PAINA61K 31/618 (2006.01) EP 2<strong>05</strong>4<strong>05</strong>1 * USE OF 2,5-DIHYDROXYBENZENE DERIVATIVES FOR TREATING ACTINIC KERATOSISA61K 31/66 (2006.01) EP 2046734 * DERIVATIVES OF 4-TRIMETHYLAMMONIUM-3-AMINOBUTYRATE AND 4-TRIMETHYLPHOSPHONIUM-3-AMINOBUTYRATE AS CPT-INHIBITORSA61K 31/661 (2006.01) EP 2046766 * AGONISTS OF THE SPHINGOSINE- 1- PHOSPHATE RECEPTOR (SLP)A61K 31/661 (2006.01) EP 2048143 * PRODRUG OF CINNAMIDE COMPOUNDA61K 31/704 (2006.01) EP 2046345 * USE OF ESCINA61K 31/7048 (2006.01) EP 2049556 * NEW MACROLIDES USEFUL AGAINST INFLAMMATORY AND ALLERGIC DISSEASESA61K 31/7<strong>05</strong>6 (2006.01) EP 2<strong>05</strong>4076 * COMBINATION THERAPY FOR TREATMENT OF VIRAL INFECTIONSA61K 31/706 (2006.01) EP 2049557 * 1- (-D-GLYCOPYRANOSYL) - 3 - (4-CYCLOPROPYLPHENYLMETHYL) - 4 - HALOGENOINDOLE DERIVATIVES AND USE THEREOF AS SGLT INHIBITORS.A61K 31/716 (2006.01) EP 2<strong>05</strong>1698 * A LIPOSOMAL COMPLEX OF SODIUM CARBOXYMETHYL BETA-GLUCANA61K 33/24 (2006.01) EP 1967189 Methods for treating resistant or refractory tumorsA61K 35/14 (2006.01) EP 2047859 * TREATMENT OF ISCHEMIC DISEASE USING ERYTHROPOIETINA61K 36/02 (2006.01) EP 2046354 * COMPONENTS THEREOF FOR THE TREATMENT OF NEUROLOGICAL,NEURODEGENERATIVE AND MOOD DISORDERSALPHANIZOMENON FLOS AQUAE PREPARATION, EXTRACTS AND PURIFIEDA61K 36/53 (2006.01) EP 2046357 * ANTIOXIDANT COMPOSITIONS COMPRISING EXTRACTS OF MYRTLE AND ROSEMARYA61K 36/61 (2006.01) EP 2046357 * ANTIOXIDANT COMPOSITIONS COMPRISING EXTRACTS OF MYRTLE AND ROSEMARYA61K 36/61 (2006.01) EP 2049133 * NEW EUCALYPTUS EXTRACT, METHOD OF PREPARATION AND THERAPEUTIC USESTHEREOFA61K 38/00 (2006.01) EP 2049136 * MITOCHONDRIA-TARGETED ANTIOXIDANTSA61K 38/00 (2006.01) EP 2<strong>05</strong>1725 * METHODS OF TREATING OBESITY USING SATIETY FACTORSA61K 38/00 (2006.01) EP 2<strong>05</strong>1728 * IMMUNOMODULATORY COMPOUNDS AND TREATMENT OF DISEASES RELATED TO ANOVERPRODUCTION OF INFLAMMATORY CYTOKINESISSN 1331-2030